• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis
Abdelrahman M Attia1, Hasmik Adetyan2, Ju Dong Yang2,3,4
1Faculty of Medicine, Cairo University, Cairo, Egypt
2Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States
3Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States
4Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States
Correspondence :  Ju Dong Yang ,
Tel: +1- 310-4231971, Fax: +1-310-4232356, Email: judong.yang@cshs.org
Received: June 25, 2024   Accepted: June 29, 2024
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 250 View
  • 15 Download
ORCID iDs

Ju Dong Yang
https://orcid.org/0000-0001-7834-9825

Related articles

Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma2023 October;29(4)

The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment2023 October;29(4)

Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging2023 July;29(3)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective2023 April;29(2)

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison2023 April;29(2)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 533
TOTAL : 1931636
Close layer